StayCurrentMD · Adrenocortical Carcinoma PDQ®
Follow
Guideline1 min read·Published Mar 2020Older

Adrenocortical Carcinoma PDQ®

Guideline · Mar 2020 · 1 min read

In brief

In brief

NCI's evidence-based clinical reference for healthcare professionals treating adrenocortical carcinoma in pediatric patients. Covers diagnostic evaluation, staging, treatment approaches, and prognostic factors for this rare endocrine malignancy in children.

  • Adrenocortical carcinoma is a rare pediatric malignancy requiring specialized multidisciplinary management.
  • Complete surgical resection remains the primary curative treatment for localized adrenocortical carcinoma.
  • Hormonal syndromes (virilization, Cushing syndrome) are common presenting features in pediatric cases.
  • Genetic predisposition (Li-Fraumeni syndrome, Beckwith-Wiedemann) should be evaluated in all pediatric patients.
  • Prognosis depends heavily on stage at diagnosis and completeness of surgical resection.

Written by the GCMD Library team from the guideline.

National Institute of Health and National Cancer Institute Childhood Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version

Read it at the source ↗

This guideline lives on cancer.gov.

Open it on cancer.gov ↗
Try
Intelligent Search· scoped to this guideline · not medical adviceSearch the whole library →